Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.95 INR | -1.00% | -.--% | -.--% |
Feb. 26 | Vivimed Labs CFO Resigns | MT |
Feb. 24 | Vivimed Labs Limited Announces Resignation of Ramakanta Tripathy as Chief Financial Officer | CI |
Business Summary
Number of employees: 607
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharma
94.0
%
| 1,961 | 82.6 % | 1,768 | 94.0 % | -9.81% |
Speciality Chemicals
6.0
%
| 412 | 17.4 % | 112 | 6.0 % | -72.77% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
100.0
%
| 2,373 | 100.0 % | 1,881 | 100.0 % | -20.74% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Santosh Varalwar
CEO | Chief Executive Officer | 62 | 89-11-08 |
Compliance Officer | - | - | |
S. G. Saurabh
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Santosh Varalwar
CEO | Chief Executive Officer | 62 | 89-11-08 |
Sandeep Varalwar
BRD | Director/Board Member | 55 | 08-01-22 |
Subhash Varalwar
BRD | Director/Board Member | 76 | 89-11-08 |
Director/Board Member | 87 | 94-11-09 | |
Chairman | - | 20-02-13 | |
Aparna Bidarkar
BRD | Director/Board Member | - | 22-02-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 82,914,000 | 61,645,419 ( 74.35 %) | 0 | 74.35 % |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Vivimed Labs Spain SL
Vivimed Labs Spain SL Pharmaceuticals: MajorHealth Technology Vivimed Labs Spain SL manufactures and distributes personal care products. The company was founded on July 5, 2011 and is headquartered in Barcelona, Spain. |
Pharmaceuticals: Major
|
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-.--% | 4.92M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- VIVIMEDLAB Stock
- Company Vivimed Labs Limited